Showing results (1781-1790 of 1,858) with videos related to
Sort By:
Pageof 186
The Journal of Infectious Diseases|April 6, 2021
Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care WorkersRicardo da Silva Antunes, Suresh Pallikkuth, Erin Williams, et al.European Journal of Medical Genetics|August 14, 2016
Copy number variation analysis in adults with catatonia confirms haploinsufficiency of SHANK3 as a predisposing factorJeroen Breckpot, Marieke Vercruyssen, Eddy Weyts, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2020
Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children's Oncology Group AREN0321 StudyNajat C Daw, Yueh-Yun Chi, John A Kalapurakal, et al.Pharmaceutics|May 28, 2022
3,6'- and 1,6'-Dithiopomalidomide Mitigate Ischemic Stroke in Rats and Blunt InflammationYan-Rou Tsai, Dong Seok Kim, Shih-Chang Hsueh, et al.Journal of Pediatric Surgery|September 24, 2024
Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531Erin G Brown, E Stanton Adkins, Peter Mattei, et al.Annals of Surgery|August 11, 2017
Results of the First Prospective Multi-institutional Treatment Study in Children With Bilateral Wilms Tumor (AREN0534): A Report From the Children's Oncology GroupPeter Ehrlich, Yuen Y Chi, Murali M Chintagumpala, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2017
Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532Conrad V Fernandez, Elizabeth A Mullen, Yueh-Yun Chi, et al.Nature Communications|March 20, 2021
trans-Translation inhibitors bind to a novel site on the ribosome and clear Neisseria gonorrhoeae in vivoZachary D Aron, Atousa Mehrani, Eric D Hoffer, et al.Oncogene|February 19, 2020
EGFRvIII upregulates DNA mismatch repair resulting in increased temozolomide sensitivity of MGMT promoter methylated glioblastomaNina Struve, Zev A Binder, Lucy F Stead, et al.Cancer|May 28, 2020
Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children's Oncology GroupPeter F Ehrlich, Yueh-Yun Chi, Murali M Chintagumpala, et al.Pageof 186